Novartis says it is expanding how India contributes to its global drug development. The company is shifting more early stage research to India while doubling down on innovative medicines. With plans to bring additional new medicines to market soon, the move signals deeper long term commitment to India’s healthcare ecosystem and its workforce.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
